Skip to main content
Log in

α2-Adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The cholinergic hypothesis of Alzheimer's disease (AD) has strongly influenced research on learning and memory over the last decade. However, there has been limited success treating AD dementia with cholinomimetics. Furthermore, there are indications that other neurotransmitter systems affected by this disease may be involved in cognitive processes. Animal studies have suggested that norepinephrine and acetylcholine may interact in learning and memory. The current experiments investigate this interaction in a step-down passive avoidance paradigm after coadministration of acetylcholinesterase inhibitors and α2-adrenoceptor antagonists. Administration of acetylcholinesterase inhibitors heptylphysostigmine (0.625–5.0 mg/kg, IP), tacrine (2.5–10.0 mg/kg, PO), velnacrine (0.312–2.5 mg/kg, SC), and galanthamine (0.312–2.5 mg/kg, IP) each enhanced retention of a passive avoidance response at selected moderate doses administered 30–60 min prior to training. The α2-adrenoceptor antagonists idazoxan (0.312–2.5 mg/kg, IP), yohimbine (0.078–0.312 mg/kg, IP) and P86 7480 (0.156–0.625 mg/kg, IP) alone failed to enhance learning in this paradigm. Coadministration of a subthreshold dose of heptylphysostigmine (0.625 mg/kg, IP) with doses of idazoxan, yohimbine or P86 7480 enhanced passive avoidance learning. This synergistic interaction may represent effects of antagonism of presynaptic α2-adrenoceptor since coadministration of heptylphysostigmine and the selective postsynaptic α2-adrenoceptor antagonist SKF104856 did not result in enhanced learning. Taken together these data suggest noradrenergic activation through pre-synaptic α2-adrenoceptor blockade may potentiate cholinergic activity in the formation of a long-term memory trace. These observations may have implications for the treatment of AD with cholinergic and adrenergic agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abercrombie ED, Keller RWJ, Zigmond MJ (1988) Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience 27:897–904

    Google Scholar 

  • Arnsten AF, Cai JX (1993) Postsynaptic alpha-2 receptor stimulation improves memory in aged monkeys: indirect effects of yohimbine versus direct effects of clonidine. Neurobiol Aging 14[6]:597–603

    Google Scholar 

  • Arnsten AF, Contant TA (1992) Alpha-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task. Psychopharmacology 108[1-2]:159–169

    Google Scholar 

  • Arnsten AF, Leslie FM (1991) Behavioral and receptor binding analysis of the alpha 2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-yl amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an alpha 2-adrenoceptor subtype. Neuropharmacology 30[12A]:1279–1289

    Google Scholar 

  • Arnsten AF, Goldman-Rakic PS (1985) Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science 230[4731]:1273–1276

    Google Scholar 

  • Bartus RT, Dean R3, Sherman KA, Friedman E, Beer B (1981) Profound effects of combining choline and piracetam on memory enhancement and cholinergic function in aged rats. Neurobiol Aging 2[21]:105–111

    Google Scholar 

  • Bartus BT, Dean III RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–416

    Google Scholar 

  • Beller SA, Overall JE, Swann AC (1985) Efficacy of oral physostigmine in primary degenerative dementia. A double-blind study of response to different dose level. Psychopharmacology 87[2]:147–151

    Google Scholar 

  • Bondareff W, Mountjoy CQ, Roth M (1982) Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 32:164–168

    Google Scholar 

  • Bondi MW, Salmon DP, Butters NM (1994) Neuropsychological features of memory disorders in Alzheimer's disease. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 41–64

    Google Scholar 

  • Cai JX, Ma YY, Xu L, Hu XT (1993) Reserpine impairs spatial working memory performance in monkeys: reversal by the alpha 2-adrenergic agonist clonidine. Brain Res 614[1-2]:191–196

    Google Scholar 

  • Clineschmidt BV, Pettibone DJ, Lotti VJ, Hucker HB, Sweeney BM, Reiss DR, Lis EV, Huff JR, Vacca J (1988) A peripherally acting alpha-2 adrenoceptor antagonist: L-659, 066. J Pharmacol Exp Ther 245[1]:32–40

    Google Scholar 

  • Connor DJ, Dietz S Langlais PJ, Thal LJ (1992) Behavioral effects of concurrent lesions of the nucleus basalis magnocellularis and the dorsal noradrenergic bundle. Exp Neurol 116[1]:69–75

    Google Scholar 

  • Costa E, Panula P, Thompson HK, Cheny DL (1983) The transsynaptic regulation of the septo-hippocampal neurons. Life Sci 32:165–179

    Google Scholar 

  • Coull JT (1994) Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition. Drugs Aging 5[2]:116–126

    Google Scholar 

  • Coyle JT, Price DL, DeLong MR (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219:1184–1190

    Google Scholar 

  • Cuadra G, Giacobini E (1995) Coadministration of cholinesterase inhibitors and idazoxan: effects of neurotransmitters in rat cortex in vivo. J Pharmacol Exp Ther 273:230–240

    Google Scholar 

  • Davis K, Thal L, Gamzu E (1992) A double-blind placebo-controlled multicenter study of tacrine for Alzheimer's disease. N Eng J Med 327:1253–1259

    Google Scholar 

  • Davis KL, Haroutunian V (1993) Strategies for the treatment of Alzheimer's disease. Neurology 43[8 Suppl. 4]:S52-S55

    Google Scholar 

  • Decker M (1992) Cholinergic/adrenergic interactions and memory. In: Levin Ed, Decker MW, Larry LB (eds) Neurotransmitter interactions and cognitive function. Birkhauser, Boston, MA, pp 78–90

    Google Scholar 

  • Decker MW, Gallagher M (1987) Scopolamine-disruption of radial arm maze performance: modification by noradrenergic depletion. Brain Res 417[1]:59–69

    Google Scholar 

  • Decker MW, McGaugh JL (1989) Effects of concurrent manipulations of cholinergic and noradrenergic function on learning and retention in mice. Brain Res 477[1–2]:29–37

    Google Scholar 

  • Decker MW, McGaugh JL (1991) The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7[2]:151–168

    Google Scholar 

  • Decker MW, Gill TM, McGaugh JL (1990) Concurrent muscarinic andβ-adrenergic blockade in rats impairs place-learning in a water maze and retention of inhibitory avoidance. Brain Res 513:81–85

    Google Scholar 

  • Dekker AJ, Connor DJ, Thal LJ (1991) The role of cholinergic projections from the nucleus basalis in memory. Neurosci Biobehav Rev 15[2]:299–317

    Google Scholar 

  • Dennis T, L'Heureux R, Carter C, Scatton B (1987) Presynaptic alpha-2-adrenoreceptors play a major role in the effects of idazoxan on cortical noradrenergic release (as measured by in vivo dialysis) in the rat. J Pharmacol Exp Ther 241:642–649

    Google Scholar 

  • Devauges V, Sara SJ (1990) Activation of the noradrenergic system facilitates an attentional shift in the rat. Behav Brain Res 39:19–28

    Google Scholar 

  • Dunnett SB, Everitt BJ, Robbins TW (1991) The basal forebraincortical cholinergic system: interpreting the functional consequences of excitotoxic lesions. Trends Neurosci 14[11]:494–501

    Google Scholar 

  • Fibiger HC (1991) Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence [see comments]. Trends Neurosci 14[6]:220–223

    Google Scholar 

  • Fibiger HC (1992) Cholinergic replacement strategies in Alzheimer's disease: the postsynaptic dilemma. Commentary on Dawson et al. “Pharmacological mechanisms and animal models of cognition. Behav Pharmacol 3:299–300

    Google Scholar 

  • Flood JF, Smith GE, Cherkin A (1985) Hydergine enhances memory in mice. J Pharmacol 3:39–49

    Google Scholar 

  • Flood JF, Smith GE, Cherkin A (1988) Memory enhancement in mice: role of drug dose and training-testing interval. Pharmacol Biochem Behav 29[3]:635–639

    Google Scholar 

  • Fulginiti S, Cancela LM (1983) Effect of naloxone and amphetamine on acquisition and memory consolidation of active avoidance responses in rats. Psychopharmacology 79[1]:45–48

    Google Scholar 

  • Gottfries CG, Adolfsson R, Acquilonius SM (1983) Biochemical changes in dementia disorders of the Alzheimer type (AD/SDAT). Neurobiol Aging 4:261–271

    Google Scholar 

  • Gower AJ (1987) Enhancement by secoverine and physostigmine of retention of passive avoidance response in mice. Psychopharmacology 91[3]:326–329

    Google Scholar 

  • Grigoryan GA, Mitchell SN, Hodges H, Sinden JD, Gray JA (1994) Are the cognitive-enhancing effects of nicotine in the rat with lesions to the forebrain cholinergic projection system mediated by an interaction with the noradrenergic system? Pharmacol Biochem Behav 49[3]:511–521

    Google Scholar 

  • Haroutunian V, Kanof PD, Tsuboyama G, Davis KL (1990) Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats. Brain Res 507[2]:261–266

    Google Scholar 

  • Hieble JP, Sulpizio AC, Edwards R, Chapman H, Young P, Roberts S, Blackburn TP, Wood MD, Shah DH, Demarinis RM, Ruffolo Jr RR (1991) Additional evidence for functional subclassification of alpha-2 adrenoreceptors based on a new selective antagonist, SK&F 104856. J Pharmacol Exp Ther 259[2]:643–652

    Google Scholar 

  • Introini-Collison IB, Miyazaki B, McGaugh JL (1991) Involvement of the amygdala in the memory-enhancing effects of clenbuterol. Psychopharmacology 104[4]:541–544

    Google Scholar 

  • Introini-Collison I, Saghafi D, Novack GD, McGaugh JL (1992) Memory-enhancing effects of post-training dipivefrin and epinephrine: involvement of peripheral and central adrenergic receptors. Brain Res 572[1–2]:81–86

    Google Scholar 

  • Martinez J Jr, Vasquez BJ, Rigter H, Messing RB, Jensen RA, Liang KC, McGaugh JL (1980) Attenuation of amphetamine-induced induced enhancement of learning by adrenal demedullation. Brain Res 195[2]:433–443

    Google Scholar 

  • Mason ST (1979) Central noradrenergic-cholinergic interaction and locomotor behavior. Eur J Pharmacol 56:131–137

    Google Scholar 

  • Mason ST, Fibiger HC (1979) Possible behavioral function for noradrenergic-acetylcholine interaction in brain. Nature 277:396–397

    Google Scholar 

  • Mesulam MM, Mufson EJ, Wainer BH, Levey AI (1983) Central cholinergic pathways in the rat: a review based on an alternative nomenclature (Ch1-Ch6). Neuroscience 10:1185–1201

    Google Scholar 

  • Moran PM, LeMaitre MH, Philouze V, Reymann JM, Allain H, Leonard BE (1992) Reversal of learning and memory impairments following lesions of the nucleus basalis magnocellularis (NBM) by current noradrenergic depletion using DSP4 in the rat. Brain Res 595:327–333

    Google Scholar 

  • Palmer AM, Francis PT, Bowen DM, Bennton JS, Neary D, Mann DMA, Snowden JS (1987) Catecholaminergic neurons assessed ante-mortem in Alzheimer's disease. Brain Res 414:365–375

    Google Scholar 

  • Riekkinen PJ, Sirvio J, Riekkinen Jr P, Valjakka A, Jakala P, Koivisto E, Lammintausta R (1992) The role of the noradrenergic system in higher cerebral functions: experimental studies about the effects of noradrenergic modulation on electrophysiology and behavior. In: Levin ED, Decker MW, Larry LB (eds) Neurotransmitter interactions and cognitive function. Birkhauser, Boston, MA, pp 91–102

    Google Scholar 

  • Riekkinen P Jr, Riekkinen M, Sirvio J (1993) Cholinergic drugs regulate passive avoidance performance via the amygdala. J Pharmacol Exp Ther 267:1484–1492

    Google Scholar 

  • Routledge C, Marsden CA (1987) Comparison of the effects of selected drugs on release of hypothalamic adrenaline and noradrenaline measured in vivo. Brain Res 426:103–111

    Google Scholar 

  • Santucci AC, Haroutunian V, Davis KL (1991) Pharmacological alleviation of combined cholinergic/noradrenergic lesion-induced memory deficits in rats. Clin Neuropharmacol 14[1]:S1-S8

    Google Scholar 

  • Sara SJ (1989) Noradrenergic-cholinergic interaction: its possible role in memory dysfunction associated with senile dementia. Arch Gerontol Geriatr Suppl 1:99–108

    Google Scholar 

  • Sara SJ, Devauges V (1989) Idazoxan, an α-2 antagonist, facilitates memory retrieval in the rat. Behav Neural Biol 51:401–411

    Google Scholar 

  • Sara SJ, Vankov A, Herve A (1994) Locus coeruleus-evoked responses in behaving rats. A clue to the role of noradrenaline in memory. Brain Res Bull 35[5–6]:457–465

    Google Scholar 

  • Selden NR, Cole BJ, Everitt BJ, Robbins TW (1990) Damage to ceruleo-cortical noradrenergic projections impairs locally cued but enhances spatially cued water maze acquisition. Behav Brain Res 39[1]:29–51

    Google Scholar 

  • Shimohama S, Taniguchi T, Fujiwara M, Kameyama M (1986) Biochemical characterization of alpha-adrenergic receptors in human brain and changes in Alzheimer-type dementia. J Neurochem 47[4]:1294–1301

    Google Scholar 

  • Smith AP, Wilson SJ, Glue P et al. (1992) The effects and after effects of the α2-adrenergic antagonist idazoxan on mood, memory, and attention in normal volunteers. J Psychopharmacol 6:376–381

    Google Scholar 

  • Soetens E, D'Hooge R, Hueting JE (1993) Amphetamine enhances human-memory consolidation. Neurosci Lett 161[1]:9–12

    Google Scholar 

  • Terry RD, Masliah E, Hansen LA (1994) Structural basis of the cognitive alterations in Alzheimer disease. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 179–196

    Google Scholar 

  • Venault P, Jacquot F, Save E, Sara S, Chapouthier G (1993) Anxiogenic-like effects of yohimbine and idazoxan in two behavioral situations in mice. Life Sci 52[7]:639–645

    Google Scholar 

  • Waterhouse BD, Moises HC, Woodward DJ (1981) Alpha-receptor-mediated facilitation of somatosensory cortical neuronal responses to excitatory synaptic inputs and iontophoretically applied acetylcholine. Neuropharmacology 20:907–920

    Google Scholar 

  • Whitehouse PJ (1993) Cholinergic therapy in dementia. Acta Neurol Scan 88[Suppl. 149]:42–45

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Camacho, F., Smith, C.P., Vargas, H.M. et al. α2-Adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat. Psychopharmacology 124, 347–354 (1996). https://doi.org/10.1007/BF02247440

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02247440

Key words

Navigation